In addition, kaliotoxin is a molecule with Kv1.3 blocking activity and can be used to treat delayed-type hypersensitivity in RA patients (Beeton et al., 2001; Wulff, 2010). This evidence concerns the gene KCNA3 and rheumatoid arthritis.